A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

(2011) Zhihu Ding et al.   NATURE

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development

(2010) T. Bianco-Miotto et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer

(2009) Jason PW Carey et al.   BMC CANCER

Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors

(2009) Itai Kela et al.   PROSTATE

A role for the androgen-receptor in clinically localized and advanced prostate cancer

(2008) James L. Mohler   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate

(2008) Olaf Bettendorf et al.   GENES CHROMOSOMES & CANCER

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

(2008) Y. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Elevated levels of HER-2/neuand androgen receptor in clinically localized prostate cancer identifies metastatic potential

(2008) Carmela Ricciardelli et al.   PROSTATE